T 2108/19 (Animal feed additive/NUTRECO) vom 06.12.2022
- Europäischer Rechtsprechungsidentifikator
- ECLI:EP:BA:2022:T210819.20221206
- Datum der Entscheidung
- 6. Dezember 2022
- Aktenzeichen
- T 2108/19
- Antrag auf Überprüfung von
- -
- Anmeldenummer
- 10702358.2
- Verfahrenssprache
- Englisch
- Verteilung
- Nicht verteilt (D)
- Download
- Entscheidung auf Englisch
- Amtsblattfassungen
- Keine AB-Links gefunden
- Weitere Entscheidungen für diese Akte
- -
- Zusammenfassungen für diese Entscheidung
- -
- Bezeichnung der Anmeldung
- ANIMAL FEED ADDITIVE AND ANIMAL FEED COMPRISING ALKYL ESTERS OF MEDIUM CHAIN FATTY ACIDS, AND THEIR USE IN ANIMAL FEED
- Name des Antragstellers
- Nutreco Nederland B.V.
- Name des Einsprechenden
- Nutrition Sciences N.V.
- Kammer
- 3.3.09
- Leitsatz
- -
- Relevante Rechtsnormen
- European Patent Convention Art 100(a)European Patent Convention Art 123(2)European Patent Convention Art 53(c)European Patent Convention Art 56European Patent Convention Art 83European Patent Convention Art 84Rules of procedure of the Boards of Appeal 2020 Art 013(2)Rules of procedure of the Boards of Appeal Art 12(4)
- Schlagwörter
- Late-filed evidence - submitted with the statement of grounds of appeal
Late-filed evidence - could have been filed in first instance proceedings (no)
Amendments - added subject-matter (no)
Sufficiency of disclosure - (yes)
Grounds for opposition - fresh ground for opposition (yes)
Inventive step - main request (yes)
Amendment after summons - taken into account (no) - Orientierungssatz
- -
- Zitierte Akten
- G 0010/91
- Zitierende Akten
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent as amended in the following version:
- claims 1-16 in accordance with the main request filed with the patent proprietor's statement setting out the grounds of appeal
- description paragraphs [0001] to [0052] as filed during the oral proceedings before the board
- drawings figures 1-3 of the patent specification.